Physician profile
Farbod Malek
NPI 1972787927
$15,610.12
in general payments reported to CMS, 2019-2025
41 companies · $1,509 in 2025
The $1,509 reported for 2025 was more than what 77% of Surgical Oncology providers received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $1,246 · 2021: $561 · 2022: $1,931 · 2023: $7,785 · 2024: $2,236 · 2025: $1,509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,971 · Consulting Fee: $5,000 · Travel and Lodging: $544 · Education: $14.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,970.59 |
| Consulting Fee | $5,000.00 |
| Travel and Lodging | $544.32 |
| Education | $14.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $5,099.78 | 2023-2024 | |
| Stryker Corporation | $5,042.25 | 2021-2025 | Mako, Insignia, Triathlon |
| Medinc of Texas | $713.15 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $678.24 | 2022-2025 | Iovera, Exparel |
| Depuy Synthes Sales INC. | $460.80 | 2019-2025 | Na, Tfn-Advance, Va-Lcp |
| Kci USA, INC. | $400.00 | 2020 | |
| Acumed LLC | $340.26 | 2023-2025 | Acumed, Innate Implant, Osteomed |
| Smith+Nephew, INC. | $288.81 | 2019-2025 | Evos, Pico 7, Stravix Pl |
| Imbed Biosciences INC. | $263.34 | 2023 | |
| Zimmer Biomet Holdings, INC. | $241.64 | 2019 | |
| Onkos Surgical, INC. | $219.79 | 2021-2025 | Eleos Limb Salvage System |
| Bioventus LLC | $148.34 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Heron Therapeutics, INC. | $125.00 | 2021 | |
| Si-Bone, INC. | $124.47 | 2021-2025 | |
| Access Pro Medical, LLC | $124.42 | 2022-2023 | Matriderm |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $121.79 | 2025 | Auvelity |
| Mission Medical Distribution, LLC | $115.27 | 2023-2025 | |
| Carbofix Orthopedics INC | $113.75 | 2023 | |
| Sanara Medtech INC. | $112.11 | 2021-2025 | Celleraterx |
| Acera Surgical, INC. | $111.07 | 2022-2025 | Restrata Wound Matrix |
| Heraeus Medical, LLC. | $82.47 | 2021-2023 | Palacos |
| Medacta USA, INC. | $76.59 | 2023 | Gmk Sphere |
| Integra Lifesciences Corporation | $74.87 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Catalyst Orthoscience | $64.83 | 2022 | |
| Convatec INC. | $60.89 | 2023 | |
| Fidia Pharma USA INC. | $59.24 | 2023-2024 | Hymovis, Triluron, Hyalgan |
| Ossdsign USA Incorporated | $40.81 | 2025 | Ossdsign Catalyst |
| Davol INC. | $32.58 | 2022-2023 | Arista Ah Flexitip |
| Jazz Pharmaceuticals INC. | $32.43 | 2023-2024 | Defitelio |
| Axogen | $27.13 | 2020 | |
| Triad Life Sciences INC. | $26.04 | 2022 | |
| Globus Medical, INC. | $24.22 | 2025 | Senza |
| Ethicon US, LLC | $21.54 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.37 | 2024 | |
| Anika Therapeutics, INC. | $21.30 | 2023 | Tactoset, Ovomotion, Anchors |
| Vericel Corporation | $19.71 | 2020 | |
| Kerecis Limited | $19.28 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Daiichi Sankyo INC. | $18.39 | 2019 | |
| Deciphera Pharmaceuticals INC. | $14.88 | 2025 | Romvimza |
| Avanos Medical | $13.99 | 2019 | |
| Boston Scientific Corporation | $13.28 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farbod Malek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.